The Magpie has landed: Preeclampsia, magnesium sulphate and rational decisions

International Journal of Obstetric Anesthesia

Volumn 11, Issue 4, 2002, Pages 238-241

  Yentis, S M ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE; PHENYTOIN;

BLOOD PRESSURE; BRAIN PROTECTION; CEREBRAL PALSY; CESAREAN SECTION; CLINICAL TRIAL; CONVULSION; DOSE RESPONSE; DRUG EFFICACY; ECLAMPSIA; EDITORIAL; FETUS DISEASE; FLUSHING; HEART ARREST; HOSPITALIZATION; HUMAN; INJECTION SITE; INTENSIVE CARE; LENGTH OF STAY; LUNG EDEMA; MATERNAL MORTALITY; MEDICAL DECISION MAKING; MUSCLE WEAKNESS; NAUSEA; NEWBORN MORTALITY; PREECLAMPSIA; PROTEINURIA; REFLEX; RESPIRATION DEPRESSION; SAMPLE SIZE; SIDE EFFECT; STROKE; TOCOLYSIS; TREATMENT OUTCOME; VOMITING;

EID: 0036792333     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1054/ijoa.2002.0995     Document Type: Editorial

References (15)

1. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet 1995; 345: 1455-1463.
2. The Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002;359: 1877-1891.
3. Lucas M J, Leveno K J, Cunningham F G. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333: 201-205.
4. Coetzee E J, Dommisse J, Anthony J. A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia. Br J Obstet Gynaecol 1998; 105: 300-303.
5. Nelson K B, Grether J K. Can magnesium sulphate reduce the risk of cerebral palsy in very low birth weight infants? Pediatrics 1995; 95: 263-269.
6. Duley L, Neilson J, Watkins K. More studies are needed before giving magnesium sulphate for pre-eclampsia. BMJ 1999; 318: 809.
7. Terrone D A, Rinehart B K, Kimmel E S, May W L, Larmon J E, Morrison J C. A prospective, randomized, controlled trial of high and low maintenance doses of magnesium sulfate for acute tocolysis. Am J Obstet Gynecol 2000; 182: 1477-1482.
8. Mittendorf R, Covert R, Boman J, Khoshnood B, Kwang-Sun L, Siegler M. Is tocolytic magnesium sulphate associated with increased total paediatric mortality? Lancet 1997; 350: 1517-1518.
9. Douglas K A, Redman C W G. Eclampsia in the United Kingdom, BMJ 1994; 309: 1395-1400.
10. Duley L, Neilson J P. Magnesium sulphate and pre-eclampsia. BMJ 1999; 319: 34.
11. Sheth S S, Chalmers I. Magnesium for preventing and treating eclampsia: time for international action. Lancet 2002; 359: 1872.
12. Burrows R F, Burrows E A. The feasibility of a control population for a randomized control trial of seizure prophylaxis in the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1995; 173; 929-935.
13. Duley L, Gulmezoglu A M, Henderson-Smart D J. Anticonvulsants for women with pre-eclampsia (Cochrane Review). In: The Cochrane Library, Issue 4, 2001. Oxford: Update Software.
14. Cook R J, Sackett D L. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995; 310: 452-454.
15. Khan K S, Chien P F W. Seizure prophylaxis in hypertensive pregnancies: a framework for making clinical decisions. Br J Obstet Gynaecol 1997; 104: 1173-1179.